| Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies N D’souza, F Rossignoli, G Golinelli, G Grisendi, C Spano, O Candini, ... BMC medicine 13 (1), 1-15, 2015 | 178 | 2015 |
| A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing M Prapa, S Caldrer, C Spano, M Bestagno, G Golinelli, G Grisendi, ... Oncotarget 6 (28), 24884, 2015 | 102 | 2015 |
| Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors G Golinelli, G Grisendi, M Prapa, M Bestagno, C Spano, F Rossignoli, ... Cancer gene therapy 27 (7), 558-570, 2020 | 96 | 2020 |
| Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine PKF Damasceno, TA de Santana, GC Santos, ID Orge, DN Silva, ... Frontiers in Cell and Developmental Biology 8, 2020 | 77 | 2020 |
| Soluble TRAIL armed human MSC as gene therapy for pancreatic cancer C Spano, G Grisendi, G Golinelli, F Rossignoli, M Prapa, M Bestagno, ... Scientific reports 9 (1), 1-14, 2019 | 70 | 2019 |
| GD2 CAR T cells against human glioblastoma M Prapa, C Chiavelli, G Golinelli, G Grisendi, M Bestagno, R Di Tinco, ... NPJ precision oncology 5 (1), 1-14, 2021 | 60 | 2021 |
| Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy F Rossignoli, G Grisendi, C Spano, G Golinelli, A Recchia, G Rovesti, ... Cancer gene therapy 26 (1), 11-16, 2019 | 57 | 2019 |
| MSC-delivered soluble TRAIL and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma F Rossignoli, C Spano, G Grisendi, EM Foppiani, G Golinelli, I Mastrolia, ... Theranostics 9 (2), 436, 2019 | 56 | 2019 |
| Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? M Dominici, G Golinelli, I Mastrolia, B Aramini, V Masciale, M Pinelli, ... Frontiers in pharmacology 11, 1544, 2020 | 28 | 2020 |
| The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma S Avnet, S Lemma, M Cortini, G Di Pompo, F Perut, MV Lipreri, ... Cancers 13 (22), 5855, 2021 | 17 | 2021 |
| Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers M Prapa, D Cerioli, S Caldrer, C Spano, M Bestagno, G Golinelli, ... Cytotherapy 18 (6), S101, 2016 | 16 | 2016 |
| Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma G Golinelli, G Grisendi, M Dall'Ora, G Casari, C Spano, R Talami, ... Translational oncology 15 (1), 101240, 2022 | 15 | 2022 |
| Tumor stroma manipulation by MSC G Grisendi, C Spano, F Rossignoli, N Dsouza, G Golinelli, A Fiori, ... Current drug targets 17 (10), 1111-1126, 2016 | 15 | 2016 |
| Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells G Golinelli, G Grisendi, C Spano, M Dominici Human Gene Therapy 25 (5), 406-407, 2014 | 10 | 2014 |
| Adipose mesenchymal stromal/stem cells expanded by a GMP compatible protocol displayed improved adhesion on cancer cells in flow conditions F Agostini, C Vicinanza, F Di Cintio, M Battiston, E Lombardi, G Golinelli, ... Annals of Translational Medicine 8 (8), 2020 | 9 | 2020 |
| A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors. G Golinelli, R Talami, S Frabetti, O Candini, G Grisendi, C Spano, ... Frontiers in cell and developmental biology 9, 767253-767253, 2021 | 5 | 2021 |
| Soluble TRAIL-Armed Human AD-MSC as Novel Cell Therapy: Approach for Pancreatic Ductal Adenocarcinoma C Spano, G Grisendi, O Candini, G Golinelli, T Petrachi, F Rossignoli, ... Cytotherapy 18 (6), S24-S25, 2016 | 3 | 2016 |
| Method for the production of bi-functional cells to treat neoplasia G Golinelli, G Grisendi, C Spano, O Candini, M Dominici US Patent App. 17/263,953, 2021 | | 2021 |
| 5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma G Golinelli, G Grisendi, M Dall'Ora, G Casari, M Prapa, C Spano, R Talami, ... Annals of Oncology 32, S2, 2021 | | 2021 |
| Targeting pancreatic ductal adenocarcinoma & its stroma by a chemo & gene therapy strategy G Grisendi, M Dall'Ora, A D'Esposito, G Casari, C Spano, O Candini, ... Cytotherapy 22 (5), S125, 2020 | | 2020 |
